Clinical Insights to Support an Investment Round

In the absence of clinical data, expert opinion is valuable, and provides prospective investors with a means of de‑risking their investment.

Our activities included:

Identifying clinicians in the UK and USA who were prominent in the treatment of glioblastoma.
Undertaking interviews with those clinicians to understand patient pathways, standard of care, unmet needs, and the clinical potential of the new treatment.
Developing a report summarising the research and describing the likely positioning in the patient pathway of the technology and its attainable price.

This is one of many projects we have undertaken involving working with start-ups to help them obtain expert opinion about their technologies, which can be included in investment brochures, grant applications, and marketing materials.